| Subgroup | Category | No. of studies | Sample size | Stages 3–5 Prevalence (95% CI) | value | I2 (%) |
| Region | Amhara Addis ababa Others | 4 3 3 | 1,208 1,136 611 | 11.13 (5.47, 16.79) 17.47 (13.88, 21.05) 16.3 (5.13, 27.46) | <0.001 0.073 <0.001 | 91.1 61.8 93.8 | Study design | Cohort Cross-sectional | 2 9 | 781 2,874 | 16.79 (11.51, 22.07) 13.92 (9.23, 18.16) | 0.047 <0.001 | 74.7 91.8 | Type of DM | Type 2 Type 1 & 2 | 2 8 | 781 2,174 | 16.79 (11.51, 22.07) 13.92 (9.23, 18.61) | 0.047 <0.001 | 74.7 91.8 | GFR equation/formula | MDRD CKD-EPI CG | 4 2 4 | 1,150 480 1,325 | 12.02 (5.62, 18.42) 10.3 (2.66, 17.94) 18.96 (14.93, 22.99) | <0.001 0.004 0.014 | 92.4 87.8 71.8 | Sampling technique | Systematic random Simple random Convenience Census | 4 2 2 3 | 1,291 560 480 1,324 | 12.34 (5.56, 19.11) 19.08 (15.82, 22.33) 10.3 (2.66, 17.94) 19.22 (8.84, 29.6) | <0.001 0.669 0.004 0.003 | 93.9 0.0 87.8 88.7 |
|
|